Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**5'-O-(L-Threonylsulfamoyl)adenosine** is a synthetic derivative of adenosine in which an L-threonyl group is linked to the adenosine molecule via a sulfamoyl bond. It is classified as a small molecule and has been primarily studied as an experimental compound. This molecule mimics the structure of aminoacyl adenylate intermediates and acts as an inhibitor of threonyl-tRNA synthetase, thereby interfering with protein synthesis by preventing the proper aminoacylation of tRNA(Thr). Its primary use has been in biochemical research to study enzyme mechanisms related to protein translation. There are no known clinical indications or approvals for this compound[1][4][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 5'-O-(L-Threonylsulfamoyl)adenosine.